Vertos Medical, founded to address common spinal diseases, focuses on developing and marketing advanced medical devices. The company's core mission is to innovate minimally invasive treatments for lumbar spinal stenosis (LSS) and improve patient outcomes. Their flagship product, the mild® procedure, offers a less invasive alternative to traditional surgery, aiming to enhance mobility and reduce pain for patients suffering from LSS. Vertos Medical targets healthcare providers and patients seeking effective, low-risk spinal treatments.
Notable figures associated with Vertos Medical include experienced leaders in the medical device industry, though specific names are not provided. The company has garnered significant investment from venture capital firms specializing in healthcare innovation. Key achievements include FDA clearance for their mild® procedure and widespread adoption by healthcare professionals. Vertos Medical's impact is evident in its contribution to improving the quality of life for patients with spinal stenosis through safer, more effective treatment options.